Inomax
Arterial Stiffness
Colorado State UniversityEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Arterial Stiffness cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dapagliflozin University Medical Centre Ljubljana | Phase 4 | BBB |
S-Equol Akira Sekikawa | Phase 2 | CCC |
ACETYLCHOLINE Colorado State University | Early Phase 1 | C |
Same molecule, other indications
Inomax is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →